EUVIMEDEUVIMED entdecken
Crossref

METTL3-Mediated m 6 A mRNA Modification Facilitates Neointimal Hyperplasia in Arteriovenous Fistula

Yao Zhao iD, Zhaozheng Li iD, Huimin Ma iD, Zhenwei Pan iD, Benzhi Cai iD, Chengwei Zhang iD, Jundong Jiao iD

Arteriosclerosis, Thrombosis, and Vascular Biology · 2025-07 · 45 (7) · 1124-1144

DOI: 10.1161/atvbaha.124.321014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2025-07. Verfasst von Yao Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The Second Affiliated Hospital of Harbin Medical University, China (Y.Z., Z.L., H.M., C.Z., J.J.). Hauptthemen laut MEDLINE: Methyltransferases, Neointima, Adenosine, RNA, Messenger. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Arteriovenous fistula (AVF) is the preferred vascular access for hemodialysis in patients with end-stage renal disease, yet its long-term patency is threatened by neointimal hyperplasia (NIH). N 6 -methyladenosine (m 6 A), a prevalent RNA modification catalyzed by METTL3 (methyltransferase-like 3), plays a regulatory role in cardiovascular remodeling. Our previous studies found that N 6 -methyladenosine methyltransferase METTL3 mediated cardiomyocyte proliferation and heart repair after myocardial ischemia. However, its impact on AVF-related NIH remains unclear. METHODS: We examined m 6 A levels and METTL3 expression in human and murine AVF tissues. Using smooth muscle cell–specific METTL3 conditional knockout and METTL3-overexpressing (adeno-associated virus–METTL3) mouse models, we evaluated NIH formation. In vitro, we analyzed vascular smooth muscle cell proliferation, migration, phenotypic switching, and ferroptosis. m 6 A epitranscriptomic microarray and RNA stability assays were used to explore downstream targets and mechanisms. RESULTS: METTL3 was significantly upregulated in AVF tissues and vascular smooth muscle cells undergoing dedifferentiation. METTL3 deletion attenuated, while overexpression exacerbated, NIH in vivo. METTL3 enhanced vascular smooth muscle cell proliferation, migration, and phenotypic switching, while suppressing ferroptosis. Mechanistically, METTL3 increased m 6 A modification of SLC7A11 (solute carrier family 7 member 11) mRNA, stabilized its transcript, and promoted translation via recruitment of the m 6 A reader YTHDF1 (YTH [YT521-B homology domain] N6-methyladenosine RNA-binding protein 1). Silencing SLC7A11 or YTHDF1 abrogated METTL3-induced phenotypic changes and ferroptosis resistance. CONCLUSIONS: The METTL3-YTHDF1-SLC7A11 axis facilitates AVF NIH by regulating vascular smooth muscle cell dedifferentiation and ferroptosis. These findings uncover a novel epitranscriptional mechanism and suggest a potential therapeutic target for AVF stenosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethyltransferasesNeointimaAdenosineRNA, MessengerMyocytes, Smooth MuscleMuscle, Smooth, VascularArteriovenous Shunt, SurgicalAnimalsHumansHyperplasiaCell ProliferationMice, KnockoutMiceDisease Models, AnimalMaleCell MovementMice, Inbred C57BLCells, CulturedRNA-Binding ProteinsRNA Stability

Stichwörter der Autor:innen

N6-methyladenosine (m6A)cell proliferationferroptosishyperplasiamethyltransferase

Substanzen

MethyltransferasesMettl3 protein, mouseMETTL3 protein, humanAdenosineN-methyladenosineRNA, MessengerRNA-Binding Proteins

Autor:innen und Institutionen

  • Department of Nephrology, The Second Affiliated Hospital of Harbin Medical University, China (Y.Z., Z.L., H.M., C.Z., J.J.).
  • Department of Pharmacy at The Second Affiliated Hospital, and Department of Pharmacology (The Key Laboratory of Cardiovascular Medicine Research, Ministry of Education) at College of Pharmacy (Z.P., B.C.), Harbin Medica…
  • Department of Clinical Pharmacology (the Heilongjiang Key Laboratory of Drug Research) (B.C.), Harbin Medical University, China.
  • Department of Nephrology, The Second Affiliated Hospital of Harbin Medical University, Heilongjiang, China (J.J.).

ORCID-Profile: Yao Zhao, Zhaozheng Li, Huimin Ma, Zhenwei Pan, Benzhi Cai, Chengwei Zhang, Jundong Jiao

Zitieren

APA

Zhao, Y., Li, Z., Ma, H., Pan, Z., Cai, B., Zhang, C., & Jiao, J. (2025). METTL3-Mediated m 6 A mRNA Modification Facilitates Neointimal Hyperplasia in Arteriovenous Fistula. Arteriosclerosis, Thrombosis, and Vascular Biology, 45(7), 1124-1144. https://doi.org/10.1161/atvbaha.124.321014

Vancouver

Zhao Y, Li Z, Ma H, Pan Z, Cai B, Zhang C, et al. METTL3-Mediated m 6 A mRNA Modification Facilitates Neointimal Hyperplasia in Arteriovenous Fistula. Arteriosclerosis, Thrombosis, and Vascular Biology. 2025;45(7):1124-1144. doi:10.1161/atvbaha.124.321014

BibTeX
@article{Zhao2025,
  author = {Zhao, Yao and Li, Zhaozheng and Ma, Huimin and Pan, Zhenwei and Cai, Benzhi and Zhang, Chengwei and Jiao, Jundong},
  title = {METTL3-Mediated m 6 A mRNA Modification Facilitates Neointimal Hyperplasia in Arteriovenous Fistula},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2025},
  volume = {45},
  number = {7},
  pages = {1124--1144},
  doi = {10.1161/atvbaha.124.321014}
}
Kostenlos starten →